Chlamydia trachomatis subverts neutrophil cell death pathways through RIP3 and Mcl-1 manipulation
mBio · 2025
DOI: 10.1128/mbio.02098-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Rebecca Koch und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Microbiology, Biocenter, University of Wuerzburg, Wuerzburg, Germany. Hauptthemen laut MEDLINE: Neutrophils, Myeloid Cell Leukemia Sequence 1 Protein, Chlamydia trachomatis, Receptor-Interacting Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chlamydia trachomatis , an obligate intracellular pathogen, manipulates host cells to evade immune detection, contributing to sexually transmitted diseases with severe complications. Neutrophils, short-lived effector cells, form the first line of innate immune defense against infection. Here, we demonstrate that Chlamydia infection extends the lifespan of human neutrophils, creating a cellular niche for its own survival. Lifespan extension involves the neutrophil PI3K/Akt- and the NF-κB signaling pathways. In addition, infection activates the necroptotic effector receptor-interacting protein kinase 3 (RIP3) without inducing cell death. Instead, RIP3 stabilizes the anti-apoptotic protein Mcl-1, enhancing neutrophil survival. This extended survival of neutrophils correlates with an increased number of infectious Chlamydia particles. Mcl-1 plays a critical role in neutrophil survival, lifespan extension, and Chlamydia survival. Notably, inhibiting RIP3 reduces Mcl-1 levels in neutrophils without affecting their survival. Under these conditions, however, Chlamydia load increases, and the dependence on Mcl-1 is bypassed. Our data reveal a new role for necroptosis in neutrophil defense against intracellular Chlamydia , highlighting a complex interplay between RIP3 and Mcl-1 that extends neutrophil lifespan and enhances Chlamydia survival within these hostile cells. IMPORTANCE This study reveals how Chlamydia trachomatis , a common sexually transmitted bacterium, manipulates the body’s first immune responders, the neutrophils, to aid its own survival. Normally short-lived, neutrophils live longer when infected by Chlamydia , creating a safe environment for the bacteria. This lifespan extension is driven by specific cell survival signals and a protein called RIP3, which surprisingly does not cause cell death here, but helps stabilize another protein, Mcl-1, that keeps neutrophils alive. Blocking RIP3 reduces Mcl-1, but Chlamydia still manages to survive, suggesting it can adapt to changes in the host environment. These findings uncover a new layer of complexity in how our immune system interacts with infections and could inform future strategies for treating Chlamydia and similar infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair of Microbiology, Biocenter, University of Wuerzburg, Wuerzburg, Germany.
ORCID-Profile: Rebecca Koch, Naveen Challagundla, Thomas Rudel
Zitieren
APA
Koch, R., Challagundla, N., Stelzner, K., & Rudel, T. (2025). Chlamydia trachomatis subverts neutrophil cell death pathways through RIP3 and Mcl-1 manipulation. mBio. https://doi.org/10.1128/mbio.02098-25
Vancouver
Koch R, Challagundla N, Stelzner K, Rudel T. Chlamydia trachomatis subverts neutrophil cell death pathways through RIP3 and Mcl-1 manipulation. mBio. 2025. doi:10.1128/mbio.02098-25
BibTeX
@article{Koch2025,
author = {Koch, Rebecca and Challagundla, Naveen and Stelzner, Kathrin and Rudel, Thomas},
title = {Chlamydia trachomatis subverts neutrophil cell death pathways through RIP3 and Mcl-1 manipulation},
journal = {mBio},
year = {2025},
doi = {10.1128/mbio.02098-25}
}
EUVIMED